|
|
Post by selluwud on Aug 18, 2020 14:45:08 GMT
I haven't found a thread for this stem cell derived allogenic cellular medicines' company out of Australia so here you go. Similar to Athersys in concept and methods of action for their therapies. Covid-19 is bringing exposure to this issue and consequentially will have trials and results sooner than later. I have recently invested here but not as heavily as I am in ATHX. GLTA
|
|
|
|
Post by selluwud on Nov 20, 2020 1:06:32 GMT
|
|
|
|
Post by selluwud on Dec 17, 2020 15:35:01 GMT
This is on trading halt until Dec.18th or sooner if the corporate update is released. Anybody have a clue? Recent heart trials flubbed endpoints and pps nosed dived, but ARDS trials are still pending. Hmmmm?
|
|
|
|
Post by JHam on Dec 17, 2020 15:58:58 GMT
This is on trading halt until Dec.18th or sooner if the corporate update is released. Anybody have a clue? Recent heart trials flubbed endpoints and pps nosed dived, but ARDS trials are still pending. Hmmmm? Very curious indeed. |
|
|
|
Post by selluwud on Dec 17, 2020 23:32:37 GMT
|
|
|
|
Post by JHam on Dec 18, 2020 0:59:00 GMT
Well it’s just the ARDS COVID trial at least, right? They have other irons in the fire no? From what I have read and researched, targeting ARDS is not the best approach to fighting severe cases of COVID. It’s just the symptom of the main issue which is inflammation leading to the cytokine storm, which leads to coagulation/clots, which then shows up in some cases as ARDS. But what do I know... Still wondering about the long halt though. Good luck here. Hope you can get out relatively unscathed. |
|
|
|
Post by selluwud on Dec 18, 2020 1:05:59 GMT
Well it’s just the ARDS COVID trial at least, right? They have other irons in the fire no? From what I have read and researched, targeting ARDS is not the best approach to fighting severe cases of COVID. It’s just the symptom of the main issue which is inflammation leading to the cytokine storm, which leads to coagulation/clots, which then shows up in some cases as ARDS. But what do I know... Still wondering about the long halt though. Good luck here. Hope you can get out relatively unscathed. The last run up was due to Covid related therapies being a success, but treating acute Graft vs Host disease in children is where their current path to better days lies. |
|
|
|
Post by selluwud on Jan 11, 2021 12:42:00 GMT
|
|
